In this article, we will take a look at the 5 pro-life companies to invest in. To see more such companies, click 10 Pro-Life Companies to Invest In.
5. Franco-Nevada Corporation (NYSE:FNV)
Franco-Nevada Corporation (NYSE:FNV) is a Canadian company that is operating in two segments: Mining and Energy. The gold-focused company posted mixed third quarter results back in November, posting an adjusted EPS of $0.83 which missed estimates by $0.03. Revenue in the period fell 3.8% to total $304.3 million. However, the company said that it was on track to meet its full-year guidance. Copper production guidance for 2022 was however slashed from 330,000 – 360,000 tonnes to 340,000 – 350,000 tonnes.
Over the past 12 months, Franco-Nevada Corporation (NYSE:FNV) shares have gained about 10%, a no ordinary feat given the market situation in 2022. The company is also a dividend payer. In January last year, its board upped the company’s quarterly dividend by 6.7%.
Here is what Horizon Kinetics has to say about Franco-Nevada Corporation (NYSE:FNV) in its Q3 2022 investor letter:
“Back to basic principles. We don’t hold gold in client portfolios, we hold gold royalty companies. The two have surprisingly little in common. The gold royalty company generates very impressive profits even if the gold price never rises, and it earns those profits year after year. Here is a long-term chart of Franco Nevada Corp., the premier gold royalty company vs. gold itself: a comparable gold price today than a decade ago, yet Franco Nevada returned 12.5% annually, matching the S&P 500 return, despite its nearsole source of revenues unchanged. What will Franco Nevada’s earnings and share price do if gold rises over the course of a decade?”
4. Haemonetics Corporation (NYSE:HAE)
Blood and plasma supplies and services company Haemonetics Corporation (NYSE:HAE) was one of those rare stocks that managed to outperform the market in 2022 by huge margins. Haemonetics Corporation (NYSE:HAE) is up about 43% over the past year. Ave Maria Value Fund has a $13.6 million stake in the company.
For the fiscal second quarter of 2023, the Massachusetts-based company easily beat expectations, posting non-GAAP EPS of $0.83, which was $01.6 above estimates. Revenue in the quarter jumped about 24% and totaled $297.48 million, beating analyst estimates by $28.26 million. The company also updated its previous fiscal 2023 GAAP total revenue growth guidance from 8% – 11% to 12% – 15% vs. consensus growth of 10%.
Haemonetics is also gaining ground among the smart money. 25 hedge funds of the 920 funds tracked by Insider Monkey ended the third quarter of last year with Haemonetics Corporation (NYSE:HAE) in their portfolios, compared to 20 funds in the previous quarter.
Here is what Heartland Value Plus Fund has to say about Haemonetics Corporation (NYSE:HAE) in its Q2 2022 investor letter:
“Haemonetics, which provides disposables and devices used for blood and plasma collection, appears to be a recession-friendly stock as its products are not economically dependent. Moreover, as households feel economic pressures, they are more likely to donate plasma, for which they are compensated.”
3. Chevron Corporation (NYSE:CVX)
Chevron Corporation (NYSE:CVX) is one of the best value stocks and also a dividend aristocrat, having raised its dividend consistently over the past 35 years. Chevron Corporation (NYSE:CVX) has historically been a right-leaning company and its addition in the Ave Maria Value Fund testifies that it’s a pro-life company. Data from the lobbying and donation record website OpenSecrets shows that most of the funding and donations from Chevron’s affiliates went to the Republicans over the past few years.
Chevron Corporation (NYSE:CVX) is making headlines after the company’s CEO Mike Wirth said in an interview to Bloomberg that the oil industry’s record profits in 2022 should not be seen in isolation and people should keep in mind that the industry was losing billions of dollars a few years back. His comments came after President Biden criticized major oil companies for making huge profits amid the Ukraine war.
Chevron Corporation (NYSE:CVX) is also a hedge fund favorite. 66 hedge funds in the database of Insider Monkey were bullish on the company as of the end of the third quarter of last year.
2. Pioneer Natural Resources Company (NYSE:PXD)
Texas-based Pioneer Natural Resources Company (NYSE:PXD) is one of the best pro-life stocks to buy according to Ave Maria Value Fund. Pioneer Natural Resources Company (NYSE:PXD) is involved in hydrocarbon exploration and is operating in the Cline Shale, which is a part of the Spraberry Trend of the Permian Basin.
The Fortune 500 company has a dividend yield of about 11% as of January 2023. In October last year, it was reported by Reuters that Pioneer Natural Resources Company (NYSE:PXD) was planning to increase its productivity levels in 2023 by reshuffling its drilling portfolio to target wells with potentially higher returns. The company is reportedly eyeing to operate 24 to 26 drilling rigs in 2023, compared to 22 to 24 rigs in 2022. The Reuters report also quoted the company’s President Richard Dealy, who said that productivity in the year was “less” and the company plans to rectify this problem. In the third quarter, the company saw a 9% year-over-year drop in oil production.
1. Texas Pacific Land Corporation (NYSE:TPL)
Texas Pacific Land Corporation (NYSE:TPL) is one of the biggest private landowners in the state of Texas. The stock accounts for about 15% of the Ave Maria Value Fund, as of the end of the third quarter. In the third quarter of 2022, the company posted GAAP EPS of $16.82, easily beating the consensus estimates by $2.44. Revenue in the period jumped about 55% to come in at $191.1 million, beating the Street estimates by $15.4 million. The company’s management said that it continues to profit from strong commodity prices and operator development activity in the Permian Basin.
Texas Pacific Land Corporation (NYSE:TPL) also has a decent standing when it comes to hedge fund popularity. As of the end of the September quarter of last year, 20 funds in Insider Monkey’s database of 920 funds had stakes in the company. The total value of these stakes was $2.7 billion.
Texas Pacific Land Corporation (NYSE:TPL) is also a dividend payer. On November 1, 2022, the company’s board announced a cash dividend of $3.00 per share, which was payable on December 15, 2022 to stockholders of record at the close of business on December 8, 2022.
Here is what Wedgewood Partners specifically said about Texas Pacific Land Corporation (NYSE:TPL) in its Q3 2022 investor letter:
“Texas Pacific Land Corporation (NYSE:TPL) was a top contributor to performance during the quarter. Revenue vaulted over +80% as oil and gas royalties more than doubled, plus water sales nearly doubled. Most of this was driven by higher realized prices on the production of oil and gas on the Company’s acreage. Production of oil and gas also grew +21%. The Company’s royalty interests span over 880,000 acres in West Texas. Most of this land is located in the highly productive Delaware Basin within the Permian Basin. We expect development activity will continue to grow at a rapid pace in this region, primarily driven by both domestic and multinational producers looking to maximize returns on increasingly scarce oil and gas capital expenditures. Further, as the tragic war in Ukraine has unfolded, energy security has become an increasingly important issue for countries around the globe. The production of hydrocarbons on Texas Pacific’s acreage represents a “port in the storm” for the U.S. and for allies too that are dependent on the energy of hostile countries. It is difficult to know how any specific policy will evolve but possessing a commanding acreage position in one of the most productive regions in the country puts the Company in an excellent strategic and competitively advantaged position.”
You can also take a peek at 10 Stocks to Buy According to Mark T. Gallogly’s Centerbridge Partners and 8 Stocks to Buy According to Alexander Captain’s Cat Rock Capital.
